Literature DB >> 32823451

Worsening of posterior scleritis and orbital pseudotumor in a patient with granulomatosis polyangiitis with rituximab-A case report.

Kalpana Babu1, B G Dharmanand2.   

Abstract

We report a case of exacerbation of posterior scleritis and orbital pseudotumor in a patient with granulomatosis polyangiitis, with initial rituximab infusion. Modifications in rituximab protocols including reduction in maintenance dose for subsequent infusions with increase in premedication dose of intravenous methyl prednisolone may be useful to prevent periinfusional flares. In this case report, we highlight a rare occurrence and modification in rituximab protocol to prevent post-infusional flare of inflammation.

Entities:  

Keywords:  Granulomatosis polyangiitis; orbital pseudotumor; refractory scleritis; rituximab

Mesh:

Substances:

Year:  2020        PMID: 32823451      PMCID: PMC7690530          DOI: 10.4103/ijo.IJO_1644_20

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  5 in total

1.  Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial.

Authors:  Eric B Suhler; Lyndell L Lim; Robert M Beardsley; Tracy R Giles; Sirichai Pasadhika; Shelly T Lee; Alexandre de Saint Sardos; Nicholas J Butler; Justine R Smith; James T Rosenbaum
Journal:  JAMA Ophthalmol       Date:  2014-05       Impact factor: 7.389

2.  Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.

Authors:  Eric B Suhler; Lyndell L Lim; Robert M Beardsley; Tracy R Giles; Sirichai Pasadhika; Shelly T Lee; Alexandre de Saint Sardos; Nicholas J Butler; Justine R Smith; James T Rosenbaum
Journal:  Ophthalmology       Date:  2014-06-20       Impact factor: 12.079

3.  Rituximab Induction and Maintenance Treatment in Patients with Scleritis and Granulomatosis with Polyangiitis (Wegener's).

Authors:  Caiyun You; Lina Ma; Andres F Lasave; C Stephen Foster
Journal:  Ocul Immunol Inflamm       Date:  2017-06-19       Impact factor: 3.070

4.  Ocular and orbital exacerbation after rituximab therapy for granulomatosis with polyangiitis.

Authors:  Chai-Bae Shih; Yin-Che Wang; Chun-Chieh Lai
Journal:  Can J Ophthalmol       Date:  2019-01-23       Impact factor: 1.882

5.  Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease.

Authors:  Lavnish Joshi; Anisha Tanna; Stephen P McAdoo; Nicholas Medjeral-Thomas; Simon R J Taylor; Gurpreet Sandhu; Ruth M Tarzi; Charles D Pusey; Sue Lightman
Journal:  Ophthalmology       Date:  2015-03-04       Impact factor: 12.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.